Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2022-04-07 00:00:00 ET · period of report 2022-04-05 · accession 0001415889-22-003935 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-07 | 2022-04-05 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $11.23 | +5 | 61.1K | +0.0% | +$56.15 |
| D | 2022-04-07 | 2022-04-05 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $45.00 | -5 | 61.1K | -0.0% | -$225 |
| D | 2022-04-07 | 2022-04-05 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $11.23 | -5 | 2,276 | -0.2% | -$56.15 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-05 | M | A | 5 | $11.23 | 61,115 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-05 | S | D | 5 | $45.00 | 61,110 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-04-05 | M | D | 5 | $11.23 | 2,276 | D | $11.23 · — to 2027-01-02 | 5 Common Stock | (F2) Currently exercisable. |